Atomoxetine
Product Description
LABORATORIOS RUBIO SA
-
Country/Region:Spain
-
On CPHI since:2015
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
Categories
Specifications
LABORATORIOS RUBIO SA
-
Country/Region:Spain
-
On CPHI since:2015
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
More Products from LABORATORIOS RUBIO SA (13)
-
Product Calcium Polystyrene Sulphonate
Treatment and prevention of hyperkalaemia in adults and children.
The product has showed efficacy in the reduction of potassium.
It is indicated for patients treated with dialysis with hyperkalaemia.
Sugar free product. Non-systemic absorption.
... -
Product Hydralazine Hydrochloride
Severe essential hypertension, when the oral route is not possible or a reduction in blood pressure is required urgently. Pre-eclampsia and eclampsia.
Registered and marketed in Spain since 1984.
CTD bibliographical dossier available.
-
Product Hydroxychloroquine Sulfate
· Rheumatoid Arthritis (joints inflammation)
· Treatment of non-acute and non-complicate Malaria attacks and prevention of Malaria
· &n... -
Product Testosterone Injectable
It is used for the testosterone replacement therapy in male hypogonadism, when testosterone deficiency has been confirmed by clinical findings and biochemical tests.
It is the generic of Reandron/Nebido®. -
Product Methylphenidate Hydrochloride IR
IR - Treatment for children (over 6 years old) and adolescents with Attention Deficit and Hyperactivity Disorder (ADHD).
First Methylphenidate Hydrochloride launched in Spain (1983) with own trademark Rubifen®.
Rubifen® is a bioequivalent generic of Ritalin® in the treatment of ... -
Product Sodium Polystyrene Sulphonate
Treatment and prevention of Hyperkalaemia in adults and children.
The product has showed efficacy in the reduction of potassium.
Sugar-free product. Non-systemic absorption.
-
Product Methylphenidate Hydrochloride MR
MR - Treatment for children (over 6 years old), adolescents and adults with Attention Deficit Hyperactivity Disorder (ADHD). Box containing 30 capsules of 10/20/30/40/60 mg. Other packs are also available.
Rubifen LA® is a bioequivalent generic of Ritalin LA® in the treatment of AD... -
Product Guanfacine Hydrochloride
Guanfacine is indicated for the treatment of Attention Deficit and Hyperactivity Disorder (ADHD) in children and adolescents (6-17 years old) for whom stimulants are not suitable, not tolerated or have been shown to be ineffective.Guanfacine must be used as a part of a comprehensive ADHD treatment programm... -
Product Lisdexamfetamine dimesylate
Treatment for Attention Deficit Hyperactivity Disorder (ADHD).
It is used in children, young people, and adults who have previously taken a methylphenidate treatment that inadequately treated their ADHD.
It is not used as a treatment for ADHD in children under 6 years of age b... -
Product Melatonin 1mg/ml Oral Solution
Sleep onset insomnia in children and adolescents (6-17 years of age) with attention deficit hyperactivity disorder (ADHD) where other healthy sleeping routines have not worked well enough.
Short-term treatment of jet lag in adults.
Strawberry flavour and contains Sorbitol.
Bibliogr... -
Product Melatonin 2mg prolonged -release
Monotherapy for the short-term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
Dose: 2 mg once daily, 1-2 hours before bedtime and after food. This dosage may be continued for up to thirteen weeks.
Modified-release melatonin... -
Product Tadalafil ODT
.Treatment of erectile dysfunction in adult males.
In order for tadalafil to be effective for the treatment of erectile dysfunction, sexual stimulation is required.
5 mg only: Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.
...
